{"transactions":[{"id":3710729,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-01-03T16:27:53.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":18168.605,"price":0.86,"value":15625.0003,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes annuity distributions of 500,000 shares from the 2017-7 Grantor Retained Annuity Trust, 500,000 shares from the 2017-8 Grantor Retained Annuity Trust, 500,000 shares from the 2017-9 Grantor Retained Annuity Trust, 250,000 shares from the 2017-10 Grantor Retained Annuity Trust, 250,000 from the 2017-11 Grantor Retained Annuity Trust and 250,000 shares from the 2017-12 Grantor Retained Annuity Trust to the reporting person on November 9, 2018 and represents a change in form of beneficial ownership."}],"balance_after":4207367.974,"source":{"system":"sec-edgar","filing":"0001179110-19-000216","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911019000216/edgar.xml","form_type":"4"}},{"id":3802974,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-10-02T17:01:42.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":10416.666,"price":1.5,"value":15624.999,"ownership":{"direct":true},"balance_after":1939199.369,"source":{"system":"sec-edgar","filing":"0001179110-18-011926","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911018011926/edgar.xml","form_type":"4"}},{"id":3876840,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T11:06:22.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":1010.02,"price":15.47,"value":15625.0094,"ownership":{"direct":true},"balance_after":1928782.703,"source":{"system":"sec-edgar","filing":"0001179110-18-009273","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911018009273/edgar.xml","form_type":"4"}},{"id":3974684,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-04-03T16:47:25.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":894.391,"price":17.47,"value":15625.01077,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes annuity distributions of 42,663 shares from the 2017-1 Grantor Retained Annuity Trust, 42,663 shares from the 2017-2 Grantor Retained Annuity Trust, 42,663 shares from the 2017-3 Grantor Retained Annuity Trust, 21,332 shares from the 2017-4 Grantor Retained Annuity Trust, 21,332 from the 2017-5 Grantor Retained Annuity Trust and 21,332 shares from the 2017-6 Grantor Retained Annuity Trust to the reporting person on February 28, 2018 and represents a change in form of beneficial ownership."}],"balance_after":1927772.683,"source":{"system":"sec-edgar","filing":"0001179110-18-005242","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911018005242/edgar.xml","form_type":"4"}},{"id":4108857,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T12:39:54.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":1363.438,"price":11.46,"value":15624.99948,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes 2,250,000 shares previously owned directly by the reporting person which were contributed to the 2017-7, 2017-8, 2017-9, 2017-10, 2017-11 and 2017-12 Grantor Retained Annuity Trusts on November 9, 2017 and represents a change in form of beneficial ownership."}],"balance_after":1734893.292,"source":{"system":"sec-edgar","filing":"0001179110-18-000481","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911018000481/edgar.xml","form_type":"4"}},{"id":4118220,"issuer":{"id":8831,"kind":"organization","name":"AUTOZONE INC","symbol":"AZO"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-01-02T21:18:57.000Z","date":"2018-01-01","kind":"grant","acquired":true,"shares":302.23,"price":711.37,"value":214997.3551,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in accordance with the Amended and Restated AutoZone, Inc. 2011 Equity Incentive Award Plan (the \"Plan\"). Pursuant to the AutoZone, Inc. 2018 Director Compensation Program (the \"2018 Program\"), directors may elect to be paid either (1) 100% of their annual retainer fees and any additional fees in the form of restricted stock units (\"RSUs\") or (2) $85,000 of their annual retainer fees and any additional fees in the form of cash, with the remaining portion of the annual retainer fee ($130,000) paid in the form of restricted stock units. All fees taken in the form of RSUs are paid annually and any portion of the fees to be paid in cash are paid on a quarterly basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock units (fully vested on the date of grant) issued to the reporting person in accordance with the Plan and the 2018 Program in lieu of the annual retainer fees in an aggregate amount equal to $215,000.  The number of shares of the issuer's common stock underlying the restricted stock unit award is equal to the reporting person's aggregate annual retainer fees, divided by the closing market price of a share of the issuer's common stock on December 29, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price per share is equal to the closing market price of a share of the issuer's common stock on December 29, 2017."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"The shares will be delivered to the reporting person upon the earlier of (a) the date on which the reporting person ceases to be a director for any reason, provided that such reporting person incurs a \"separation from service\" from the issuer (within the meaning of Section 409A of the Internal Revenue Code and the related Treasury Regulations) (the \"Termination Date\") or (b) the fifth anniversary of the grant date, in which event the reporting person will have an opportunity to re-defer the delivery of the shares up to one year prior to the fifth anniversary; unless the reporting person has irrevocably elected in writing by December 31, 2017, to defer the delivery of such shares until the Termination Date."}],"balance_after":71930.2,"source":{"system":"sec-edgar","filing":"0001225208-18-000084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/866787/000122520818000084/doc4.xml","form_type":"4"}},{"id":4132417,"issuer":{"id":8831,"kind":"organization","name":"AUTOZONE INC","symbol":"AZO"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-12-14T21:14:25.000Z","date":"2017-12-13","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in accordance with the AutoZone, Inc. 2003 Director Stock Option Plan."}],"balance_after":0,"derivative":{"exercise_price":119.145,"exercise_date":"2011-01-01","expiration_date":"2018-01-01","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001225208-17-018670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/866787/000122520817018670/doc4.xml","form_type":"4"}},{"id":4132416,"issuer":{"id":8831,"kind":"organization","name":"AUTOZONE INC","symbol":"AZO"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-14T21:14:25.000Z","date":"2017-12-13","kind":"exercise","acquired":true,"shares":3000,"price":119.145,"value":357435.0,"ownership":{"direct":true},"balance_after":71627.97,"source":{"system":"sec-edgar","filing":"0001225208-17-018670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/866787/000122520817018670/doc4.xml","form_type":"4"}},{"id":4192759,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-04T16:05:48.000Z","date":"2017-10-02","kind":"grant","acquired":true,"shares":1967.884,"price":7.94,"value":15624.99896,"ownership":{"direct":true},"balance_after":3983529.854,"source":{"system":"sec-edgar","filing":"0001179110-17-013086","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911017013086/edgar.xml","form_type":"4"}},{"id":4198316,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock Warrants (right to buy)","published_at":"2017-10-02T16:14:10.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":678349,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,130,582 immediately separable Units purchased by the reporting person for $8.845 per Unit.  Each Unit consists of one share of Common Stock and one warrant to purchase 0.60 of a share of Common Stock."}],"balance_after":678349,"derivative":{"exercise_price":9.02,"exercise_date":"2017-09-29","expiration_date":"2022-09-29","underlying":"Common Stock","underlying_shares":678349},"source":{"system":"sec-edgar","filing":"0001179110-17-012838","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911017012838/edgar.xml","form_type":"4"}},{"id":4198315,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-02T16:14:10.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":1130582,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 1,130,582 immediately separable Units purchased by the reporting person for $8.845 per Unit.  Each Unit consists of one share of Common Stock and one warrant to purchase 0.60 of a share of Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes annuity distributions 20,043 shares from the 2014-4 Grantor Retained Annuity Trust, 1,336 shares from the 2014-5 Grantor Retained Annuity Trust and 1,336 shares from the 2014-6 Grantor Retained Annuity Trust to the reporting person on August 19, 2017 and represents a change in form of beneficial ownership."}],"balance_after":3981561.97,"source":{"system":"sec-edgar","filing":"0001179110-17-012838","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911017012838/edgar.xml","form_type":"4"}},{"id":4265919,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T17:51:00.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":2970.533,"price":5.26,"value":15625.00358,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes annuity distributions 195,654 shares from the 2015-1 Grantor Retained Annuity Trust, 97,827 shares from the 2015-2 Grantor Retained Annuity Trust, 65,218 shares from the 2015-3 Grantor Retained Annuity Trust,195,654 shares from the 2015-4 Grantor Retained Annuity Trust and 195,654 shares from the 2015-5 Grantor Retained Annuity Trust to the reporting person on May 13, 2017 and represents a change in form of beneficial ownership."}],"balance_after":2828264.97,"source":{"system":"sec-edgar","filing":"0001179110-17-010009","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911017010009/edgar.xml","form_type":"4"}},{"id":4359139,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-04-05T16:59:20.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":3188.775,"price":4.9,"value":15624.9975,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes 2,250,000 shares previously owned directly by the reporting person which were contributed to the 2017-1, 2017-2, 2017-3, 2017-4, 2017-5 and 2017-6 Grantor Retained Annuity Trusts on February 28, 2017 and represents a change in form of beneficial ownership."}],"balance_after":2075287.437,"source":{"system":"sec-edgar","filing":"0001179110-17-005782","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911017005782/edgar.xml","form_type":"4"}},{"id":4504767,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T17:03:49.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":2999.041,"price":5.21,"value":15625.00361,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On December 5, 2016, the Issuer effected a one-for-ten reverse stock split of its Common Stock (the \"Reverse Split\").  The number of securities beneficially owned by the Reporting Person has been adjusted to reflect the Reverse Split."}],"balance_after":4322098.662,"source":{"system":"sec-edgar","filing":"0001179110-17-000264","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911017000264/edgar.xml","form_type":"4"}},{"id":4508895,"issuer":{"id":8831,"kind":"organization","name":"AUTOZONE INC","symbol":"AZO"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-01-03T21:37:02.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":259.56,"price":789.79,"value":204997.8924,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in accordance with the Amended and Restated AutoZone, Inc. 2011 Equity Incentive Award Plan (the \"Plan\"). Pursuant to the AutoZone, Inc. 2016 Director Compensation Program (the \"2016 Program\"), directors may elect to be paid either (1) 100% of their annual retainer fees and any additional fees in the form of restricted stock units (\"RSUs\") or (2) $80,000 of their annual retainer fees and any additional fees in the form of cash, with the remaining portion of the annual retainer fee ($125,000) paid in the form of restricted stock units. All fees taken in the form of RSUs are paid annually and any portion of the fees to be paid in cash are paid on a quarterly basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock units (fully vested on the date of grant) issued to the reporting person in accordance with the Plan and the 2016 Program in lieu of the annual retainer fees in an aggregate amount equal to $205,000.  The number of shares of the issuer's common stock underlying the restricted stock unit award is equal to the reporting person's aggregate annual retainer fees, divided by the closing market price of a share of the issuer's common stock on December 30, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price per share is equal to the closing market price of a share of the issuer's common stock on December 30, 2016."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"The shares will be delivered to the reporting person upon the earlier of (a) the date on which the reporting person ceases to be a director for any reason, provided that such reporting person incurs a \"separation from service\" from the issuer (within the meaning of Section 409A of the Internal Revenue Code and the related Treasury Regulations) (the \"Termination Date\") or (b) the fifth anniversary of the grant date, in which event the reporting person will have an opportunity to re-defer the delivery of the shares up to one year prior to the fifth anniversary; unless the reporting person has irrevocably elected in writing by December 31, 2016, to defer the delivery of such shares until the Termination Date."}],"balance_after":68627.97,"source":{"system":"sec-edgar","filing":"0001225208-17-000099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/866787/000122520817000099/doc4.xml","form_type":"4"}},{"id":4573674,"issuer":{"id":8831,"kind":"organization","name":"AUTOZONE INC","symbol":"AZO"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-10-27T21:49:48.000Z","date":"2016-10-27","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted in accordance with the AutoZone, Inc. 2003 Director Stock Option Plan."}],"balance_after":0,"derivative":{"exercise_price":116.345,"exercise_date":"2010-01-01","expiration_date":"2017-01-01","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001225208-16-040794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/866787/000122520816040794/doc4.xml","form_type":"4"}},{"id":4573673,"issuer":{"id":8831,"kind":"organization","name":"AUTOZONE INC","symbol":"AZO"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-10-27T21:49:48.000Z","date":"2016-10-27","kind":"exercise","acquired":true,"shares":3000,"price":116.345,"value":349035.0,"ownership":{"direct":true},"balance_after":68368.41,"source":{"system":"sec-edgar","filing":"0001225208-16-040794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/866787/000122520816040794/doc4.xml","form_type":"4"}},{"id":4579254,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-17T16:17:52.000Z","date":"2016-10-14","kind":"grant","acquired":true,"shares":7716049,"price":0.81,"value":6249999.69,"ownership":{"direct":true},"balance_after":43191009.21,"source":{"system":"sec-edgar","filing":"0001179110-16-030749","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911016030749/edgar.xml","form_type":"4"}},{"id":4588328,"issuer":{"id":89585,"kind":"organization","name":"Oncternal Therapeutics, Inc.","symbol":"ONCT"},"owners":[{"id":161402,"kind":"person","name":"HYDE JOSEPH R III","position":1,"cik":"0000903352","reported_name":"HYDE JOSEPH R III","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-10-04T17:02:28.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":20559.21,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes annuity distributions of 1,853,096 shares from the 2014-4 Grantor Retained Annuity Trust, 123,540 shares from the 2014-5 Grantor Retained Annuity Trust and 123,540 shares from the 2014-6 Grantor Retained Annuity Trust to the reporting person on August 19, 2016 and represents a change in form of beneficial ownership."}],"balance_after":35474960.24,"source":{"system":"sec-edgar","filing":"0001179110-16-030309","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/903352/000117911016030309/edgar.xml","form_type":"4"}}]}